RecruitingNCT07476495
Insights on Dissemination of Lung Cancer
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Enrollment
100 participants
Start Date
Feb 1, 2026
Study Type
OBSERVATIONAL
Conditions
Summary
In patients with resectable NSCLC treated with surgery alone or with surgery as part of a multimodal treatment; CTC, ctDNA, STAS, and lymph node micrometastasis levels will be evaluated to see if they are associated with recurrence patterns and long-term outcomes.
Eligibility
Min Age: 18 Years
Inclusion Criteria5
- Age ≥ 18 years;
- Preoperative diagnosis of resectable stage cIA-cIIIA NSCLC (adenocarcinoma or squamous cell carcinoma);
- Patients deemed fit for surgical or multimodal treatment;
- Informed consent obtained;
- Treatment, including multimodal treatment, involving surgery.
Exclusion Criteria4
- Histology other than adenocarcinoma or squamous cell carcinoma;
- Other neoplastic diseases concurrent with or undergoing treatment or treated with systemic therapies in the previous three years;
- Age \<18 years;
- No need for surgery.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07476495